Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.
Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.
Quoin制药的股票上涨，因为公司宣布已获得FDA批准启动新的QRX003奈瑟顿综合症临床研究。
Quoin Pharmaceuticals Shares Are Trading Higher After the Company Announced It Received FDA Clearance to Initiate a New QRX003 Netherton Syndrome Clinical Study.
Quoin制药的股票上涨，因为公司宣布已获得FDA批准启动新的QRX003奈瑟顿综合症临床研究。
资讯热榜
更新时间